Aegis Capital Starts Heron Therapeutics (HRTX) at Buy

October 26, 2016 7:35 AM EDT
Get Alerts HRTX Hot Sheet
Price: $13.30 -3.97%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade HRTX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aegis Capital initiated coverage on Heron Therapeutics (NASDAQ: HRTX) with a Buy rating and a price target of $41.00.

For an analyst ratings summary and ratings history on Heron Therapeutics click here. For more ratings news on Heron Therapeutics click here.

Shares of Heron Therapeutics closed at $15.90 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Add Your Comment